This PLoS One study demonstrates that methylene blue combined with vitamin B12 effectively alleviates experimental septic shock by modulating specific cellular pathways (KCNMB1 and cGMP-PRKG), addressing circulatory failure and microvascular dysfunction. The research validates a synergistic mechanism between two compounds often used separately in vasodilatory shock management. For practitioners, this finding supports the rationale for combined MB+VB12 protocols in critical care and suggests potential applications beyond sepsis in other conditions involving vascular dysfunction and metabolic dysregulation.
For your business
Combined MB and B12 reduced circulatory failure markers in septic shock models via cGMP-PRKG pathway modulation, supporting rationale for dual-agent protocols.